logo

For the Inventor, By the Inventor

Utrecht, Netherlands

Esther C W Breij

This inventor holds 13 USPTO granted patents and 18 published patent applications. Top assignees: Genmab A+s, Biontech Se, Ganmab A/s. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esther C W Breij. Retrieved from https://idiyas.com/inventor/esther-c-w-breij

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Utrecht, NL (2021 - 2024)
  • Driebergen, NL (2022 - 2024)

Company Filing History:

goldMedal12 out of 107 
 
Genmab A+s
 patents
silverMedal1 out of 74 
 
Biontech Se
 patents
bronzeMedal1 out of 1 
 
Ganmab A/s
 patent
4. 1 out of 9 
 
Msd International Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...
13 patents (USPTO):Explore Patents
1. 12453781 - Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugate (2025-10-28),
2. 12410258 - Antibodies capable of binding to OX40, variants thereof and uses thereof (2025-09-09),
3. 12324841 - Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate (2025-06-10),
4. 12246025 - Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate (2025-03-11),
5. 11970544 - Antibodies (2024-04-30),
6. 11858995 - Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia (2024-01-02),
7. 11845805 - Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma (2023-12-19),
8. 11814437 - Antibodies binding to CD30 and CD3 (2023-11-14),
9. 11608383 - Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma (2023-03-21),
10. 11535679 - Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma (2022-12-27),
11. 11261254 - Antibodies (2022-03-01),
12. 11130819 - Antibodies (2021-09-28),
13. 11008399 - Antibodies (2021-05-18),

Title: Inventor Esther C W Breij

Introduction: Esther C W Breij is a pioneering inventor based in Utrecht, Netherlands, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Esther C W Breij holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices, showcasing his versatility and forward-thinking approach.

Career Highlights: Throughout his illustrious career, Esther C W Breij has received numerous accolades for his inventive spirit and has been recognized for his significant impact on the industry. His inventions have revolutionized the way we approach challenges in different sectors.

Collaborations: Esther C W Breij has collaborated with leading research institutions, universities, and companies worldwide to further develop and implement his inventions. His collaborative efforts have led to the successful commercialization of several groundbreaking technologies.

Conclusion: Esther C W Breij's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of various industries with his remarkable creations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…